IGBA Claims That 2022 WHO Biosimilar Guideline Boosts Access
According to the new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline from the International Generic...
According to the new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline from the International Generic...
Two neglected tropical illnesses, lymphatic filariasis and onchocerciasis, will receive a combined investment of about 790-million-yen ($5.3 million) from the...
Seven CEOs of pharmaceutical companies, including GSK, AstraZeneca, Merck, Roche, Novo Nordisk, Samsung Biologics, and Sanofi, have launched a collaborative effort to...
The majority of consumers base their first impression of a business and its sustainability credentials on the product packaging. With...
According to a market analysis, the global oral solid dosage (OSD) contract manufacturing market is forecast to grow $54.7 billion...
The growth of the domestic pharmaceutical industry and a reduction in reliance on imports might be facilitated by funding AI-based...
A new cold chain facility being built by Etihad Cargo, Etihad Airport Services, and Abu Dhabi Airports will more than...
Due to safety concerns, advisors to the European Medicines Agency on November 11th suggested restricting the use of a class...
As stated by the Centers for Disease Control and Prevention, Omicron subvariants will soon account for the bulk of new...
Australia is the first country in the world to have awarded regulatory approval for faeces transplants. The healthy genetic material...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.